Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

More precise, personalized therapies are needed for autoimmune diseases.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Retinoids can change the hair growth cycle by extending the growth phase and shortening the rest phase.

Laser Doppler velocimetry is a valuable noninvasive tool for skin blood flow research in dermatology.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

88% phenol is effective for treating alopecia areata.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Androgen use may increase the risk of stroke, but more research is needed.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Plant hormones have potential in agriculture to increase food production but require more research for effective use.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Exosomes may help with hair growth and scar healing, but more research is needed.